Found: 98
Select item for more details and to access through your institution.
Fungaemia caused by obstructive renal candida bezoars leads to bilateral chorioretinitis: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort.
- Published in:
- Urologia Internationalis, 2022, v. 106, n. 11, p. 1150, doi. 10.1159/000521661
- By:
- Publication type:
- Article
Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
- Published in:
- Urologia Internationalis, 2018, v. 101, n. 1, p. 16, doi. 10.1159/000488466
- By:
- Publication type:
- Article
Primary Urethral Plasmacytoma Treated with High-Dose-Rate Brachytherapy: A Case Report.
- Published in:
- Urologia Internationalis, 2016, v. 97, n. 3, p. 369, doi. 10.1159/000445298
- By:
- Publication type:
- Article
Seminoma Clinical Stage 1 - Patterns of Care in Germany.
- Published in:
- Urologia Internationalis, 2016, v. 96, n. 4, p. 390, doi. 10.1159/000443214
- By:
- Publication type:
- Article
Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
- Published in:
- Urologia Internationalis, 2016, v. 96, n. 1, p. 39, doi. 10.1159/000438868
- By:
- Publication type:
- Article
Alterations of Global Histone H3K9 and H3K27 Methylation Levels in Bladder Cancer.
- Published in:
- Urologia Internationalis, 2014, v. 93, n. 1, p. 113, doi. 10.1159/000355467
- By:
- Publication type:
- Article
Diagnostic Meaning of Urodynamic Studies in Pouch Incontinence: Results of a Small Series.
- Published in:
- Urologia Internationalis, 2014, v. 92, n. 2, p. 237, doi. 10.1159/000353417
- By:
- Publication type:
- Article
Thulium Laser (Revolix) Vapoenucleation of the Prostate Is a Safe Procedure in Patients with an Increased Risk of Hemorrhage.
- Published in:
- Urologia Internationalis, 2012, v. 88, n. 4, p. 390, doi. 10.1159/000336874
- By:
- Publication type:
- Article
The N<sup>6</sup>‐methyladenosine (m<sup>6</sup>A) erasers alkylation repair homologue 5 (ALKBH5) and fat mass and obesity‐associated protein (FTO) are prognostic biomarkers in patients with clear cell renal carcinoma.
- Published in:
- BJU International, 2020, v. 125, n. 4, p. 617, doi. 10.1111/bju.15019
- By:
- Publication type:
- Article
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 1, p. 138, doi. 10.1002/ijc.23057
- By:
- Publication type:
- Article
Low Plasma Appearance of (+)-Catechin and (−)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa—A Randomized, Double-Blind Trial.
- Published in:
- Nutrients, 2020, v. 12, n. 1, p. 231, doi. 10.3390/nu12010231
- By:
- Publication type:
- Article
Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 11, p. 1, doi. 10.1002/cti2.1472
- By:
- Publication type:
- Article
Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 10, p. 1, doi. 10.1002/cti2.1471
- By:
- Publication type:
- Article
C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 12, p. 1, doi. 10.1002/cti2.1358
- By:
- Publication type:
- Article
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01775
- By:
- Publication type:
- Article
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7165, doi. 10.3390/ijms23137165
- By:
- Publication type:
- Article
ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 1117, doi. 10.3390/ijms21031117
- By:
- Publication type:
- Article
N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
YRNA expression predicts survival in bladder cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 4, p. 535, doi. 10.1007/s00428-023-03557-y
- By:
- Publication type:
- Article
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
- Published in:
- Oncology Letters, 2018, v. 16, n. 3, p. 3013, doi. 10.3892/ol.2018.9014
- By:
- Publication type:
- Article
Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
- Published in:
- Clinical Epigenetics, 2018, v. 10, p. 1, doi. 10.1186/s13148-018-0444-9
- By:
- Publication type:
- Article
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0270-x
- By:
- Publication type:
- Article
Brief communication: Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177–prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177-prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Lutetium-177--prostate-specific membrane antigen ligand following radium-223 treatment in men with bone-metastatic castration-resistant prostate cancer: real-world clinical experience.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262240
- By:
- Publication type:
- Article
Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.
- Published in:
- BMC Urology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12894-024-01460-5
- By:
- Publication type:
- Article
Bellmunt risk score as a survival predictor in patients with metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2024, v. 84, n. 12, p. 1119, doi. 10.1002/pros.24747
- By:
- Publication type:
- Article
Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy.
- Published in:
- Prostate, 2024, v. 84, n. 8, p. 772, doi. 10.1002/pros.24694
- By:
- Publication type:
- Article
Emotion‐centered versus fact‐centered medical information to alleviate pain and anxiety in prostate biopsy: A randomized trial.
- Published in:
- Prostate, 2024, v. 84, n. 4, p. 389, doi. 10.1002/pros.24659
- By:
- Publication type:
- Article
N<sup>6</sup>‐Methyladenosine (m<sup>6</sup>A) readers are dysregulated in renal cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2021, v. 60, n. 5, p. 354, doi. 10.1002/mc.23297
- By:
- Publication type:
- Article
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-023-05579-0
- By:
- Publication type:
- Article
Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2417, doi. 10.1007/s00432-022-04083-1
- By:
- Publication type:
- Article
MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 2, p. 791, doi. 10.1007/s00432-022-03915-4
- By:
- Publication type:
- Article
Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 9, p. 2255, doi. 10.1007/s00432-020-03278-8
- By:
- Publication type:
- Article
Testicular seminoma clinical stage 1: treatment outcome on a routine care level.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1599, doi. 10.1007/s00432-016-2162-z
- By:
- Publication type:
- Article
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 5, p. 823, doi. 10.3390/diagnostics13050823
- By:
- Publication type:
- Article
Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0117284
- By:
- Publication type:
- Article
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0025787
- By:
- Publication type:
- Article
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05188-7
- By:
- Publication type:
- Article
Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 1, p. 19, doi. 10.1007/s00345-022-04230-w
- By:
- Publication type:
- Article
Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients' expectancy?
- Published in:
- World Journal of Urology, 2022, v. 40, n. 9, p. 2239, doi. 10.1007/s00345-022-04083-3
- By:
- Publication type:
- Article
Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 8, p. 1639, doi. 10.1007/s00345-018-2575-1
- By:
- Publication type:
- Article
YRNA expression in prostate cancer patients: diagnostic and prognostic implications.
- Published in:
- World Journal of Urology, 2018, v. 36, n. 7, p. 1073, doi. 10.1007/s00345-018-2250-6
- By:
- Publication type:
- Article
Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 12, p. 1945, doi. 10.1007/s00345-015-1572-x
- By:
- Publication type:
- Article